Researchers at The University of Texas at Austin have developed a menu of 61 new strains of genetically engineered bacteria that may improve the efficacy of vaccines for diseases such as flu, pertussis, cholera and HPV.
Biotechnology
Jan 15, 2013
5
0
When you get a cut, blood starts to flow from the wound. But very quickly, complex biochemical processes spring into action, creating a scaffolding of molecules to block the hole, and then building up an impervious clot to ...
Materials Science
Jan 9, 2013
0
0
Researchers at the universities of Chicago and Wisconsin-Madison raise the possibility of designing ultrastable glasses at the molecular level via a vapor-deposition process. Ultrastable glasses could find potential applications ...
Condensed Matter
Jan 6, 2013
0
0
(Phys.org)—Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed the first synthetic compound that can reverse the effects of a serious metabolic condition known as fatty liver disease. ...
Biochemistry
Dec 19, 2012
0
1
Scientists from the RIKEN Advanced Science Institute in Japan and University of California Los Angeles report a new nanoscale Velcro-like device that captures and releases tumor cells that have broken away from primary tumors ...
Bio & Medicine
Dec 17, 2012
0
0
A glass plate with a nanoscale roughness could be a simple way for scientists to capture and study the circulating tumor cells that carry cancer around the body through the bloodstream.
Bio & Medicine
Dec 11, 2012
0
0
Scientists have gained fresh insights into how the salmonella bug makes us ill.
Cell & Microbiology
Dec 11, 2012
0
0
An international group of scientists working at the SLAC National Accelerator Laboratory has mapped a weak spot in the parasite that causes African sleeping sickness, pinpointing a promising new target for treating a disease ...
Biochemistry
Nov 29, 2012
0
0
.jpg)
(Phys.org)—Scientists at the University of Bristol, together with collaborators at the University of Aveiro, Portugal, have solved the structure of an enzyme that breaks down carbapenems, antibiotics 'of last resort' which, ...
Analytical Chemistry
Nov 9, 2012
0
0
When someone develops liver cancer, the disease introduces a very subtle difference to their bloodstream, increasing the concentration of a particular molecule by just 10 parts per billion.
Analytical Chemistry
Oct 26, 2012
0
0
